Ashton Thomas Securities LLC Has $689,000 Stake in UnitedHealth Group Incorporated $UNH

Ashton Thomas Securities LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 56.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,209 shares of the healthcare conglomerate’s stock after purchasing an additional 793 shares during the period. Ashton Thomas Securities LLC’s holdings in UnitedHealth Group were worth $689,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Sullivan Wood Capital Management LLC bought a new stake in UnitedHealth Group in the second quarter valued at $447,000. Hilltop National Bank bought a new stake in UnitedHealth Group in the second quarter valued at $1,420,000. Matauro LLC increased its stake in UnitedHealth Group by 169.3% in the second quarter. Matauro LLC now owns 2,704 shares of the healthcare conglomerate’s stock valued at $843,000 after purchasing an additional 1,700 shares in the last quarter. Triad Wealth Partners LLC increased its position in shares of UnitedHealth Group by 11.0% during the second quarter. Triad Wealth Partners LLC now owns 2,591 shares of the healthcare conglomerate’s stock worth $808,000 after acquiring an additional 257 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in shares of UnitedHealth Group by 15.8% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 154,874 shares of the healthcare conglomerate’s stock worth $48,316,000 after acquiring an additional 21,177 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 1.4%

UNH opened at $353.26 on Friday. The stock has a market cap of $319.94 billion, a price-to-earnings ratio of 15.31, a PEG ratio of 2.27 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company’s 50-day moving average price is $306.25 and its two-hundred day moving average price is $356.57. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. Piper Sandler decreased their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Finally, JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.